FLOWTRIEVER CATHETER, S
Device
Inari Medical, Inc.
Total Payments
$21.3M
Transactions
114,396
Doctors
26,577
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $5.6M | 45,009 | 14,508 |
| 2023 | $6.7M | 37,349 | 12,433 |
| 2022 | $6.8M | 21,701 | 7,037 |
| 2021 | $2.2M | 10,337 | 4,093 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10.9M | 7,924 | 51.2% |
| Food and Beverage | $6.4M | 102,187 | 30.1% |
| Consulting Fee | $1.7M | 641 | 8.1% |
| Travel and Lodging | $1.6M | 3,372 | 7.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $505,639 | 214 | 2.4% |
| Grant | $165,000 | 3 | 0.8% |
| Education | $9,855 | 51 | 0.0% |
| Honoraria | $2,300 | 4 | 0.0% |
Payments by Type
Research
$10.9M
7,924 transactions
General
$10.4M
106,472 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| THE PEERLESS STUDY | Inari Medical, Inc. | $4.2M | 0 |
| FLOWTRIEVER ALL-COMER REGISTRY FOR PATIENT SAFETY AND HEMODYNAMICS (FLASH) | Inari Medical, Inc. | $3.2M | 0 |
| THEPEERLESSIISTUDY | Inari Medical, Inc. | $1.4M | 0 |
| THEPEERLESSSTUDY (PEERLESS) | Inari Medical, Inc. | $784,417 | 0 |
| FLOWTRIEVER FOR ACUTE MASSIVE PULMONARY EMBOLISM (FLAME) | Inari Medical, Inc. | $629,377 | 0 |
| Validation of SEARCH | Inari Medical, Inc. | $176,441 | 0 |
| FLOWTRIEVER2 PULMONARY EMBOLECTOMY CLINICAL STUDY (FLARE-FT2) | Inari Medical, Inc. | $139,556 | 0 |
| FlowTriever2 Pulmonary Embolectomy Clinical Study (FLARE-FT2) | Inari Medical, Inc. | $107,379 | 0 |
| Validation of SEARCH, a novel hierarchical algorithm to define long-term outcomes after PE | Inari Medical, Inc. | $50,904 | 0 |
| Treatment of Low-Risk Sub-Massive Pulmonary Embolism with FlowTriever: Safety and Outcomes | Inari Medical, Inc. | $46,354 | 1 |
| Characterization of Residual Pulmonary Vascular Obstruction in Pulmonary Embolism Patients Treated with FlowTriever | Inari Medical, Inc. | $46,319 | 0 |
| The PERSEVERE Study | Inari Medical, Inc. | $42,027 | 0 |
| A Retrospective and Prospective Registry Evaluation of Technical Efficacy and Clinical Outcomes of Mechanical Thrombectomy in Cancer Patients | Inari Medical, Inc. | $34,293 | 0 |
| Characterization of Pulmonary Embolectomy Specimens with Light and Electron Microscopy | Inari Medical, Inc. | $24,000 | 1 |
| End-tidal CO2 in Patients with Pulmonary Embolism | Inari Medical, Inc. | $16,876 | 0 |
| FLARE FT2 | Inari Medical, Inc. | $15,300 | 0 |
| Pulmonary ventilation and perfusion scintigraphy | Inari Medical, Inc. | $14,174 | 1 |
| ASCENT (Artificial intelligence to StrategiCally Enhance pulmonary embolismresponse Team activation | Inari Medical, Inc. | $8,400 | 0 |
| DVT Study | Inari Medical, Inc. | $7,500 | 0 |
| FlowTriever: Safety and Outcomes | Inari Medical, Inc. | $6,700 | 0 |
Top Doctors Receiving Payments for FLOWTRIEVER CATHETER, S
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Tyler Yee | — | Mount Clemens, MI | $11.1M | 8,501 |
| , MD, MBA | Vascular & Interventional Radiology | Newport Beach, CA | $166,211 | 217 |
| , M.D | Cardiovascular Disease | Southfield, MI | $139,189 | 92 |
| , M.D | Cardiovascular Disease | Colts Neck, NJ | $110,913 | 10 |
| , PA | Physician Assistant | Grand Rapids, MI | $106,632 | 121 |
| , MD | Anesthesiology | Grand Rapids, MI | $94,548 | 121 |
| , M.D | Vascular & Interventional Radiology | Miami, FL | $86,532 | 117 |
| , MD | Student in an Organized Health Care Education/Training Program | Miami, FL | $81,250 | 132 |
| , MD | Internal Medicine | Erie, PA | $75,803 | 281 |
| , MD | Vascular & Interventional Radiology | Indianapolis, IN | $68,567 | 187 |
| , M.D | Vascular & Interventional Radiology | Brooklyn, NY | $64,452 | 89 |
| , MD | Diagnostic Radiology | Grand Rapids, MI | $63,881 | 77 |
| , M.D | Vascular Surgery | Shenandoah, TX | $63,333 | 114 |
| , M.D | Vascular Surgery | Washington, DC | $62,902 | 102 |
| , PA-C | Physician Assistant | Clearwater, FL | $59,254 | 150 |
| , M.D | Cardiovascular Disease | Torrance, CA | $53,434 | 37 |
| Catalin Toma | Interventional Cardiology | Pittsburgh, PA | $50,209 | 36 |
| , MD | Cardiovascular Disease | Columbus, OH | $45,993 | 71 |
| , M.D | Vascular Surgery | Aurora, CO | $41,537 | 19 |
| , M.D | Emergency Medicine | Detroit, MI | $41,361 | 37 |
| , MD | Pulmonary Disease | Philadelphia, PA | $40,417 | 88 |
| Nicholas Mouawad | Student in an Organized Health Care Education/Training Program | West Branch, MI | $35,744 | 155 |
| , M.D | Vascular Surgery | Tucson, AZ | $35,013 | 71 |
| , DO | Cardiovascular Disease | Columbus, OH | $33,538 | 43 |
| Efthymios Avgerinos | Vascular Surgery | Pittsburgh, PA | $33,530 | 21 |
Ad
Manufacturing Companies
- Inari Medical, Inc. $21.3M
Product Information
- Type Device
- Total Payments $21.3M
- Total Doctors 26,577
- Transactions 114,396
About FLOWTRIEVER CATHETER, S
FLOWTRIEVER CATHETER, S is a device associated with $21.3M in payments to 26,577 healthcare providers, recorded across 114,396 transactions in the CMS Open Payments database. The primary manufacturer is Inari Medical, Inc..
Payment data is available from 2021 to 2024. In 2024, $5.6M was paid across 45,009 transactions to 14,508 doctors.
The most common payment nature for FLOWTRIEVER CATHETER, S is "Unspecified" ($10.9M, 51.2% of total).
FLOWTRIEVER CATHETER, S is associated with 20 research studies, including "THE PEERLESS STUDY" ($4.2M).